Definium Therapeutics Inc. Common Shares vs PPL Corporation Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while PPL Corporation Common Stock trades at $34.08 (market cap $25.55B). The key difference: PPL Corporation Common Stock is far larger — about 5.4× Definium Therapeutics Inc. Common Shares's market cap, and PPL Corporation Common Stock pays a 3.36% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and PPL Corporation Common Stock for 0 Days on average.
| DFTX | PPL | |
|---|---|---|
Market Cap | $4.71B | $25.55B |
Volume | 1,966,636 | 6,874,595 |
Sector | Health | Utilities |
52-Week High | $48.45 | $39.81 |
52-Week Low | $10.68 | $31.97 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $45.54B |
Dividend Yield | — | 3.36% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →PPL Corporation is a regulated utility holding company. Through its subsidiaries, it generates, transmits, distributes, and sells electricity and natural gas in Kentucky, Pennsylvania, and Rhode Island.
Read more on PPL →